Security
F-star Therapeutics Inc. Common Stock · FSTX
FSTXNASDAQCommon stockHistorical · closed Mar 9, 2023CIK 1566373Updated Nov 16, 2026
Name history
Spring Bank Pharmaceuticals, Inc. · through Nov 9, 2020
FSTX price & chart
Historical security
This listing closed Mar 9, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2021 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 123,021,000Source | 63,609,000Source | 63,197,000Source | 68,811,000Source |
| Property, Plant and Equipment, NetUSD | 887,000Source | 789,000Source | 2,234,000Source | 2,319,000Source |
| GoodwillUSD | 14,898,000Source | 14,926,000Source | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 18,765,000Source | 18,986,000Source | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 78,549,000Source | 18,526,000Source | 28,709,000Source | 14,724,000Source |
| Assets, CurrentUSD | 84,739,000Source | 26,065,000Source | 57,977,000Source | 49,287,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 3,879,000Source | 3,976,000Source | 3,522,000Source | 1,649,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,281,000Source | 2,782,000Source | 2,717,000Source | — |
| Other Assets, NoncurrentUSD | 451,000Source | 61,000Source | 35,000Source | 167,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 26,164,000Source | 20,615,000Source | 27,671,000Source | 12,951,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | — | — |
| Common Stock, Value, IssuedUSD | 2,000Source | 1,000Source | 2,000Source | 2,000Source |
| Additional Paid in CapitalUSD | 176,808,000Source | 91,238,000Source | 161,924,000Source | 157,931,000Source |
| Retained Earnings (Accumulated Deficit)USD | -78,451,000Source | -47,168,000Source | -126,165,000Source | -102,068,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -1,502,000Source | -1,077,000Source | -235,000Source | -5,000Source |
| Stockholders' Equity Attributable to ParentUSD | 96,857,000Source | 42,994,000Source | 35,526,000Source | 55,860,000Source |
| Liabilities and EquityUSD | 123,021,000Source | 63,609,000Source | 63,197,000Source | 68,811,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 12,135,000Source | 16,977,000Source | 5,406,000Source | 4,247,000Source |
| Operating Lease, Liability, CurrentUSD | 906,000Source | 539,000Source | 355,000Source | — |
| Accounts Payable, CurrentUSD | 3,081,000Source | 4,597,000Source | 2,210,000Source | 1,880,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,723,000Source | 2,622,000Source | 2,869,000Source | — |
| Other Liabilities, NoncurrentUSD | — | — | 27,000Source | 193,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 6,241,000Source | 9,461,000Source | 2,438,000Source | 2,367,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | 766,000Source | — |
| Long-term DebtUSD | 9,605,000Source | — | 19,070,000Source | — |
| Long-term Debt, Current MaturitiesUSD | — | 0Source | — | — |
cash flow · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -31,283,000Source | -25,619,000Source | -24,097,000Source | -22,854,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | — | — | 357,000Source | 288,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 6,898,000Source | 3,489,000Source | — | — |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | -1,499,000Source | -2,847,000Source | 330,000Source | 180,000Source |
| Deferred Income Tax Expense (Benefit)USD | 569,000Source | 0Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -27,267,000Source | -16,226,000Source | -29,055,000Source | -25,244,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -643,000Source | 14,049,000Source | 23,498,000Source | -25,103,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 658,000Source | — | 272,000Source | 1,972,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 88,099,000Source | 15,850,000Source | 19,542,000Source | 41,172,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 60,189,000Source | 13,673,000Source | 13,985,000Source | -9,175,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 536,000Source | — | 53,000Source | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 6,898,000Source | 3,489,000Source | 3,367,000Source | 2,776,000Source |
| Amortization of Debt Issuance CostsUSD | 92,000Source | — | — | — |
| Amortization of Intangible AssetsUSD | 100,000Source | — | — | — |
| DepreciationUSD | 562,000Source | 1,144,000Source | 357,000Source | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 95,000Source | -338,000Source | — | — |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | 400,000Source | 400,000Source | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 9,000Source | -7,000Source | — | — |
| General and Administrative ExpenseUSD | 23,131,000Source | 19,513,000Source | 9,751,000Source | 8,719,000Source |
| GoodwillUSD | 14,898,000Source | 14,926,000Source | — | — |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | — | — | — |
| Impairment of Intangible Assets, Finite-livedUSD | 80,000Source | 0Source | — | — |
| Income Tax Expense (Benefit)USD | -372,000Source | -1,000Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -31,283,000Source | -25,619,000Source | -24,097,000Source | -22,854,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | -25,619,000Source | — | -27,471,000Source |
| Operating Lease, ExpenseUSD | 500,000Source | — | — | — |
| Other Nonoperating Income (Expense)USD | -941,000Source | -849,000Source | — | — |
| Proceeds from Issuance of Common StockUSD | 78,346,000Source | — | — | 37,960,000Source |
| Proceeds from Issuance of Long-term DebtUSD | 9,845,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Total RevenueUSD | 21,167,000Source | 11,256,000Source | — | — |
| Operating Income (Loss)USD | -30,714,000Source | -22,385,000Source | -33,021,000Source | -28,470,000Source |
| Other Nonoperating Income (Expense)USD | -941,000Source | -849,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -31,655,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | -372,000Source | -1,000Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -31,283,000Source | -25,619,000Source | -24,097,000Source | -22,854,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -1.46Source | -1.59Source |
| Earnings Per Share, DilutedUSD per share | — | — | -1.46Source | -1.88Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 16,454,083Source | 14,372,174Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 16,454,083Source | 14,618,976Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 100,000Source | — | — | — |
| Costs and ExpensesUSD | 51,881,000Source | 33,641,000Source | 33,021,000Source | 28,470,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 95,000Source | -338,000Source | — | — |
| General and Administrative ExpenseUSD | 23,131,000Source | 19,513,000Source | 9,751,000Source | 8,719,000Source |
| Interest ExpenseUSD | 844,000Source | — | 542,000Source | — |
| Investment Income, NetUSD | — | — | 1,254,000Source | 999,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | -25,619,000Source | — | -27,471,000Source |
| Operating Lease, ExpenseUSD | 500,000Source | — | — | — |
| Research and Development ExpenseUSD | 28,750,000Source | 14,128,000Source | 23,270,000Source | 19,751,000Source |